YARNO WENDY L 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
YARNO WENDY L
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-13+3,350→ 13,700 total - Award
Restricted Stock Units
2025-06-12+2,954→ 2,954 total→ Common Stock (2,954 underlying) - Exercise/Conversion
Restricted Stock Units
2025-06-13−3,350→ 0 total→ Common Stock (3,350 underlying) - Award
Stock Option (right to buy)
2025-06-12+4,540→ 4,540 totalExercise: $40.95Exp: 2035-06-11→ Common Stock (4,540 underlying)
Footnotes (5)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F3]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F4]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F5]RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.